Science Explorer Back to mapMap
Discussion
Researcher · UCLouvain · Belgium

Ana Beloqui

Ana Beloqui publishes mostly in Pharmaceutical Science, Molecular Biology and Endocrinology, Diabetes and Metabolism, on topics such as Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems and Inflammatory Bowel Disease.

ORCID 0000-0003-4221-3357 OpenAlex
World rank
#152,803
of 7,710,434 ranked researchers
Rank in Belgium
#1,078
of 67,186
Works
67
Citations
4.1k
Citations per work
61.7
h-index
32
i10-index 50Top 9.2% in Pharmaceutical Science
Ana Beloqui

What does Ana Beloqui research?

Ana Beloqui's work is mostly in Pharmacology, Toxicology and Pharmaceutics (27%), Biochemistry, Genetics and Molecular Biology (19%), Medicine (11%).

Life Sciences: 31 works · 46.4% of their workPharmacology, Toxicology and Pharmaceutics: 18 works · 27.0% of their workPharmaceutical Science: 18 works · 27.0% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 19.4% of their workMolecular Biology: 9 works · 13.3% of their workGenetics: 4 works · 6.1% of their workEverything else: 26 works · 38.3% of their workHealth Sciences: 10 works · 15.3% of their workMedicine: 8 works · 11.2% of their workEndocrinology, Diabetes and Metabolism: 4 works · 6.6% of their workEpidemiology: 3 works · 4.6% of their workNursing: 3 works · 4.1% of their workNutrition and Dietetics: 3 works · 4.1% of their workTHEIR WORKAna Beloqui67works
Life Sciences46%Health Sciences15%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Pharmacology, Toxicology and Pharmaceutics1827.0%
    2. Biochemistry, Genetics and Molecular Biology1319.4%
  2. Everything else2638.3%
    1. Medicine811.2%
    2. Nursing34.1%
  1. 1Pharmaceutical Science27% of their works
  2. 2Molecular Biology13% of their works
  3. 3Endocrinology, Diabetes and Metabolism7% of their works
  4. 4Genetics6% of their works
  5. 5Epidemiology5% of their works
  6. 6Nutrition and Dietetics4% of their works

Research topics

Which keywords describe Ana Beloqui's research?

The keywords of their largest research topics: Nanoparticles, Drug Delivery, Chitosan, Mucosal, Cyclodextrins, Solid Dispersions, Crohn's Disease and Inflammatory Bowel Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Nanoparticles453 topics
  2. Drug Delivery392 topics
  3. Chitosan321 topic
  4. Mucosal321 topic
  5. Cyclodextrins141 topic
  6. Solid Dispersions141 topic
  7. Crohn's Disease121 topic
  8. Inflammatory Bowel Disease121 topic
  9. RNA Interference111 topic
  10. siRNA Delivery111 topic
  11. Lipid Rafts81 topic
  12. Membrane Lipids81 topic
  13. Cancer Therapy71 topic
  14. Microneedles71 topic
  15. Nanocarriers71 topic
  16. Solid Lipid Nanoparticles71 topic
  17. Bioavailability61 topic
  18. Curcumin61 topic

Where does Ana Beloqui work?

Ana Beloqui's main affiliation in the publication record is UCLouvain, Belgium.

How many publications and citations does Ana Beloqui have?

OpenAlex counts 67 works and 4,135 citations for Ana Beloqui, an h-index of 32, ranking #152,803 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Ana Beloqui

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ana Beloqui. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.